Quote:
Originally Posted by haertig
Even more mystifying to me is that they shut down distribution of the AstraZeneca vaccine because there were reports of blood clots following injection. Then they found out that the incidence of blood clots following the vaccine was actually quite a bit lower than the incidence of blood clots in the unvaccinated population. So they started the distribution back up again. Now, I just read that they shut it down again ... for blood clots.
Apparently, AstraZeneca may be a preventative treatment for blood clots, not a cause of them.
I would have expected that when someone yelled, "Oh my God, we have a blood clot!" that the first thing someone of a scientific mind would have asked is, "Well, what is the incidence of blood clots in the general population?" Evidently that did not happen in this case, and they shut things down, panicked the population, and probably created a significant resistance to get vaccinated.
My actual concern here is that it is the media that is saying this stuff. And they have about zero credibility at this point. So I don't know what's true or what's really going on over there in Europe. But if you believe what the media is saying (quite a big stretch there!), then it is a bit puzzling what is happening.
|
This might help explain : Australian Technical Advisory Group on Immunisation (ATAGI) statement on AstraZeneca vaccine in response to new vaccine safety concerns ==>>
https://www.health.gov.au/news/atagi...afety-concerns
And Professor Allen Cheng, Co-chair of ATAGI has written this ==>> Why AstraZeneca was dropped for Pfizer for Australians under 50 —
https://www.smh.com.au/national/why-...09-p57hrv.html